WNT16 and prostate cancer: Although our validation recovered genes known to be associated with NFκB and prostate cancer (S8–S11 Tables) and the majority of our predictions were co-expressed in lethal prostate cancer (S6 and S7 Figs, S15 Table), we did not recover all known genes, e.g. WNT16 or TP53.